YayaNews LogoYaya Financial News
美股Neutral$OCS

Oculis to acquire worldwide rights to Privosegtor from Accure (OCS:NASDAQ)

Oculis (OCS) acquires global rights to Privosegtor (ACT-01) and ACT-02 for $3.8M plus shares, ending royalties and milestones—read the deal terms.

Financial news writer0 ViewsSource Seeking Alpha

YayaNews contributes financial news and market context through the YayaNews editorial workflow.

Oculis to acquire worldwide rights to Privosegtor from Accure (OCS:NASDAQ)
Image Source: Seeking Alpha

Oculis (OCS) acquires global rights to Privosegtor (ACT-01) and ACT-02 for $3.8M plus shares, ending royalties and milestones—read the deal terms.

Oculis to acquire worldwide rights to Privosegtor from Accure (OCS:NASDAQ) | Seeking Alpha

Oculis Holding (

OCS

) has entered into an asset purchase

agreement

to acquire the worldwide rights to Privosegtor and ACT-02 from Accure Therapeutics for $3.8M in upfront cash and up to 2.05M ordinary shares, the companies said Monday.

This acquisition will result

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search field

Entering text into the input field will update the search result below

Recommended For You

More

Trending News

See More

»

Disclaimer

Original YayaNews editorial coverage, published for informational purposes.

This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.

Share

Topics & Symbols

Topics & symbols

Continue Reading

Previous & next

Related Reading

Go to Channel